442 related articles for article (PubMed ID: 2744015)
1. Biochemical markers of bone turnover, intact serum parathyroid horn and renal calcium excretion in patients with pseudohypoparathyroidism and hypoparathyroidism before and during vitamin D treatment.
Kruse K; Kracht U; Wohlfart K; Kruse U
Eur J Pediatr; 1989 Apr; 148(6):535-9. PubMed ID: 2744015
[TBL] [Abstract][Full Text] [Related]
2. Skeletal responsiveness to parathyroid hormone in pseudohypoparathyroidism.
Kanatani M; Sugimoto T; Kaji H; Ikeda K; Chihara K
Eur J Endocrinol; 2001 Mar; 144(3):263-9. PubMed ID: 11248746
[TBL] [Abstract][Full Text] [Related]
3. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism.
Lambert PW; Hollis BW; Bell NH; Epstein S
J Clin Invest; 1980 Oct; 66(4):782-91. PubMed ID: 7419719
[TBL] [Abstract][Full Text] [Related]
4. [Pseudohypoparathyroidism: investigations of the serum parathyroid hormone level, pte resistance and urinary camp excretion before and during vitamin d treatment (author's transl)].
Stögmann W
Wien Klin Wochenschr Suppl; 1975; 33():1-15. PubMed ID: 176830
[TBL] [Abstract][Full Text] [Related]
5. Evidence for bone remodeling but lack of calcium mobilization response to parathyroid hormone in pseudohypoparathyroidism.
Breslau NA; Moses AM; Pak CY
J Clin Endocrinol Metab; 1983 Sep; 57(3):638-44. PubMed ID: 6688258
[TBL] [Abstract][Full Text] [Related]
6. Pseudohypoparathyroidism and idiopathic hypoparathyroidism: relationship between serum calcium and parathyroid hormone levels and urinary cyclic adenosine-3',5'-monophosphate response to parathyroid extract.
Werder EA; Fischer JA; Illig R; Kind HP; Bernasconi S; Fanconi A; Prader A
J Clin Endocrinol Metab; 1978 Jun; 46(6):872-9. PubMed ID: 233700
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of serum osteocalcin as an index of altered bone metabolism.
Kruse K; Kracht U
Eur J Pediatr; 1986 Apr; 145(1-2):27-33. PubMed ID: 3015628
[TBL] [Abstract][Full Text] [Related]
8. An investigation of the biological activity of parathyroid hormone in pseudohypoparathyroidism: comparison with vitamin D deficiency.
Allgrove J; Chayen J; Jayaweera P; O'Riordan JL
Clin Endocrinol (Oxf); 1984 May; 20(5):503-14. PubMed ID: 6744632
[TBL] [Abstract][Full Text] [Related]
9. The relationship between serum intact parathyroid hormone and calcium in idiopathic hypoparathyroidism.
Mizunashi K; Furukawa Y; Abe K; Yoshinaga K
Calcif Tissue Int; 1993 Dec; 53(6):378-83. PubMed ID: 8293350
[TBL] [Abstract][Full Text] [Related]
10. [Plasma vitamin D metabolites in parathyroid diseases (author's transl)].
Unakami H
Nihon Naibunpi Gakkai Zasshi; 1982 Mar; 58(3):234-47. PubMed ID: 6980145
[TBL] [Abstract][Full Text] [Related]
11. Sigmoidal curve shift in idiopathic hypoparathyroidism and pseudohypoparathyroidism.
Mizunashi K; Furukawa Y; Goto MM; Abe K
Calcif Tissue Int; 1998 Apr; 62(4):290-4. PubMed ID: 9504951
[TBL] [Abstract][Full Text] [Related]
12. [Parathyroid and bone. Bone metabolism in hypoparathyroidism].
Okazaki R
Clin Calcium; 2007 Dec; 17(12):1852-7. PubMed ID: 18057660
[TBL] [Abstract][Full Text] [Related]
13. Effects of active vitamin D3 and parathyroid hormone on the serum osteocalcin in idiopathic hypoparathyroidism and pseudohypoparathyroidism.
Mizunashi K; Furukawa Y; Miura R; Yumita S; Sohn HE; Yoshinaga K
J Clin Invest; 1988 Sep; 82(3):861-5. PubMed ID: 2843573
[TBL] [Abstract][Full Text] [Related]
14. The modulatory effect of endogenous parathyroid hormone on the action of hydrochlorothiazide in pseudohypoparathyroidism type I.
Mizunashi K; Furukawa Y; Abe K; Yoshinaga K
Calcif Tissue Int; 1994 Jun; 54(6):473-6. PubMed ID: 8082049
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of pseudohypoparathyroidism type I from the aspect of urinary excretion of calcium and serum levels of parathyroid hormone.
Mizunashi K; Furukawa Y; Sohn HE; Miura R; Yumita S; Yoshinaga K
Calcif Tissue Int; 1990 Apr; 46(4):227-32. PubMed ID: 2108792
[TBL] [Abstract][Full Text] [Related]
16. The renal response to exogenous parathyroid hormone in treated pseudohypoparathyroidism.
Stone MD; Hosking DJ; Garcia-Himmelstine C; White DA; Rosenblum D; Worth HG
Bone; 1993; 14(5):727-35. PubMed ID: 8268047
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of 1,25-dihydroxyvitamin D production by parathyroid hormone and dibutyryl 3',5'-cyclic AMP in normal subjects, hypoparathyroidism and pseudohypoparathyroidism.
Unakami H; Furukawa Y; Sohn HE; Yumita S; Miura R; Hanew K; Yoshinaga K
Tohoku J Exp Med; 1982 Oct; 138(2):167-75. PubMed ID: 6294914
[TBL] [Abstract][Full Text] [Related]
18. A simplified diagnostic test in hypoparathyroidism and pseudohypoparathyroidism type I with synthetic 1-38 fragment of human parathyroid hormone.
Kruse K; Kracht U
Eur J Pediatr; 1987 Jul; 146(4):373-7. PubMed ID: 2820733
[TBL] [Abstract][Full Text] [Related]
19. Serum intact parathyroid hormone concentration measured by a two-site immunoradiometric assay in normal subjects and patients with various parathyroid disorders.
Okazaki R; Matsumoto T; Furukawa Y; Fujimoto Y; Niimi H; Seino Y; Fujita T; Nagataki S; Ogata E
Endocrinol Jpn; 1992 Feb; 39(1):115-20. PubMed ID: 1606913
[TBL] [Abstract][Full Text] [Related]
20. The administration of an active vitamin D(3) analogue reduced the serum concentrations of 1-84 and truncated parathyroid hormone in pseudohypoparathyroidism type Ib patients.
Ishii A; Imanishi Y; Kurajoh M; Nagata Y; Kobayashi K; Miki T; Inaba M; Nishizawa Y
Endocr J; 2010; 57(7):609-14. PubMed ID: 20508384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
